Overview

Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation

Status:
WITHDRAWN
Trial end date:
2025-12-15
Target enrollment:
Participant gender:
Summary
This research study will test how well hyperpigmentation treatment works for subjects with mild-to-moderate facial hyperpigmentation. The study will also test if the hyperpigmentation treatment causes any irritation. For 12 weeks of the study, participants will use the assigned treatment, along with a provided cleanser and sunscreen.
Phase:
PHASE2
Details
Lead Sponsor:
Kayuraeffect, LLP
Collaborator:
COD Research
Treatments:
Sunscreening Agents